Andrea Kündgen

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

Detlef Haase, Ulrich Germing, Julie Schanz et al. · Blood · 2007 · 789 citations · Full text

Life Sciences, Genetics, Oncology +16

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML

Sabine Käyser, Konstanze Döhner, Jürgen Krauter et al. · Blood · 2010 · 485 citations

Medicine, Hematology, Oncology +11

<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group

Verena I. Gaidzik, Lars Bullinger, Richard F. Schlenk et al. · Journal of Clinical Oncology · 2011 · 450 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features

Verena I. Gaidzik, Veronica Teleanu, Elli Papaemmanuil et al. · Leukemia · 2016 · 283 citations

Medicine, Genetics, Molecular Genetics +16

Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells

Stefanie Geyh, Simin Öz, R-P Cadeddu et al. · Leukemia · 2013 · 228 citations

Life Sciences, Cell Biology, Molecular Biology +6